Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation during pregnancy.

S Schenk

    Nurse Practitioner Forum
    |June 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Anticoagulants during pregnancy require careful consideration for both mother and fetus. Subcutaneous heparin, with patient education and monitoring, can minimize risks associated with pregnancy anticoagulation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Temporal overexpression of SIRT1 in skeletal muscle of adult mice does not improve insulin sensitivity or markers of mitochondrial biogenesis.

    Acta physiologica (Oxford, England)·2017
    Same author

    Relatively low endogenous fatty acid mobilization and uptake helps preserve insulin sensitivity in obese women.

    International journal of obesity (2005)·2014
    Same author

    A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats.

    Molecular psychiatry·2013
    Same author

    Skeletal muscle-specific overexpression of SIRT1 does not enhance whole-body energy expenditure or insulin sensitivity in young mice.

    Diabetologia·2013
    Same author

    [Indolent volar swelling of the finger].

    Der Radiologe·2012
    Same author

    Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.

    Diabetologia·2012
    Same journal

    Promoting healthy behaviors in HIV primary care.

    Nurse practitioner forum·2002
    Same journal

    Primary care of HPV management in HIV-infected women.

    Nurse practitioner forum·2002
    Same journal

    Complications of HIV: lipodystrophy, anemia, renal, cardiovascular, and bone diseases.

    Nurse practitioner forum·2002
    Same journal

    HIV postexposure prophylaxis after sexual assault.

    Nurse practitioner forum·2002
    Same journal

    Primary care: promoting sexual health and HIV prevention through risk assessment and client education.

    Nurse practitioner forum·2002
    Same journal

    HIV/AIDS update.

    Nurse practitioner forum·2002
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Pharmacology
    • Maternal-Fetal Medicine

    Background:

    • Anticoagulation is sometimes necessary during pregnancy to manage life-threatening maternal thrombosis.
    • Oral anticoagulants, like warfarin, pose risks of fetal anomalies.
    • Balancing maternal health needs with fetal safety is critical in anticoagulant therapy during pregnancy.

    Purpose of the Study:

    • To evaluate the safety and efficacy of anticoagulation strategies during pregnancy.
    • To identify methods for reducing fetal and maternal risks associated with anticoagulant use in pregnant patients.

    Main Methods:

    • Review of existing literature on anticoagulant use in pregnancy.
    • Analysis of risks and benefits of different anticoagulant classes (oral vs. subcutaneous heparin).

    Related Experiment Videos

  • Emphasis on patient education and close monitoring protocols.

    • Main Results:

    • Oral anticoagulants are linked to adverse fetal outcomes.
    • Subcutaneous heparin, when managed with patient education and monitoring, demonstrates a favorable risk profile.
    • Careful management can mitigate risks for both the mother and the developing fetus.

    Conclusions:

    • Subcutaneous heparin is a preferred anticoagulant option during pregnancy when indicated.
    • Comprehensive patient education and vigilant monitoring are essential for safe anticoagulation in pregnancy.
    • Effective management strategies can significantly reduce fetal and maternal complications.